Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

OBJECTIVES: Our knowledge about the effect of tocilizumab (TCZ) on the synovium in rheumatoid arthritis (RA) is limited. The aim of this study was to investigate the effect of TCZ on citrullination and on inflammation in the synovial tissue and in the peripheral blood. METHODS: 15 patients with RA u...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzidionysiou, Katerina, Circiumaru, Alexandra, Rethi, Bence, Joshua, Vijay, Engstrom, Marianne, Hensvold, Aase, af Klint, Erik, Catrina, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194335/
https://www.ncbi.nlm.nih.gov/pubmed/34112702
http://dx.doi.org/10.1136/rmdopen-2021-001662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194335/
https://www.ncbi.nlm.nih.gov/pubmed/34112702
http://dx.doi.org/10.1136/rmdopen-2021-001662

Ejemplares similares